biodesix announces new data presentation at chest 2024 annual meeting and the launch of a complementary clinical study
LOUISVILLE, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced that...